Exhibit at TechCrunch Disrupt 2026: Get in front of 10,000 decision-makers before space runs out

If startup visibility, traction, and real deals matter, you should be on the TechCrunch Disrupt 2026 exhibit floor. Get your 6′ exhibit table before your competitor does.

2 days left: Get 50% off a second pass to TechCrunch Disrupt 2026

Two days left to save up to $410 on your pass, and get a second one at 50% off to TechCrunch Disrupt 2026. Offer ends May 8, 11:59 p.m. PT. Register now.

3 days left to lock in 50% off a second ticket to TechCrunch Disrupt 2026

Three days left to lock in 50% off a second ticket to Disrupt 2026. Buy one TechCrunch Disrupt 2026 ticket, and get a second ticket at 50% off. Gain more visibility in the tech industry. Offer ends May 8 at 11:59 p.m. PT.

4 days left: Get 50% off a second TechCrunch Disrupt 2026 pass to make more deals faster

For the next four days only, you can buy one pass to TechCrunch Disrupt 2026 and get 50% off a second of the same ticket type. That window closes May 8 at 11:59 p.m. PT. After that, prices go up, and you’ll pay more to bring a partner or colleague. Reg…

5 days only: Bring a partner or colleague and get 50% off a second TechCrunch Disrupt 2026 pass

The BOGO offer is live. For a limited time, buy one pass to TechCrunch Disrupt 2026 and get 50% off a second of the same ticket type. Offer ends this Friday, May 8. Save here.

In Harvard study, AI offered more accurate diagnoses than emergency room doctors

A new study examines how large language models perform in a variety of medical contexts, including real emergency room cases — where at least one model seemed to be more accurate than human doctors.

Musely secures $360M from General Catalyst without giving up equity

The DTC skin, hair, and menopause care brand will use the non-dilutive capital to super-charge customer acquisition.

AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter.

10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.

Aloe Blacc’s fame means nothing in biotech (and that’s the point)

When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a che…